Journal of the American Society of Nephrology, Vol 7, 183-190, Copyright © 1996 by American Society of Nephrology

REVIEWS

Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy

MP Cohen and FN Ziyadeh
Department of Biochemistry, University of Pennsylvania School of Medicine, Philadelphia, USA.

Accelerated nonenzymatic glycation in diabetes, resulting in Amadori- modified proteins and the later-developing advanced glycation end- products, has been mechanistically linked to the pathogenesis of diabetic nephropathy. Recent focus on putative AGE-induced pathophysiology has shifted attention from the possible role of Amadori- modified proteins in the development of diabetic complications. Ample experimental evidence has demonstrated that Amadori-modified serum proteins adversely affect renal glomerular capillary function, structure, and metabolism. Previous studies from the laboratories of this study's authors have shown that human serum containing diabetic concentrations of albumin modified by Amadori-glucose adducts inhibits the replication of murine mesangial cells in culture and stimulates the production and gene expression of type IV collagen. Monoclonal antibodies (A717) specific for Amadori-glycated albumin prevent these abnormalities. In other studies, it has also been shown that in vivo administration of A717 (Fab fragments) retards the progression of diabetic nephropathy in diabetic db/db mice. Neutralizing the effects of the elevated circulating glycated albumin concentration is associated with reduction in proteinuria and mesangial matrix expansion, and prevention of the overexpression of mRNA encoding type IV collagen and fibronectin in the renal cortex. The renoprotective effects of A717 are independent of any change in blood glucose concentrations. These studies implicate Amadori-modified glycated albumin in the pathogenesis of diabetic nephropathy. It is proposed in this study that abrogating the biologic effects of increased glycated albumin in diabetes has novel therapeutic potential in the management of diabetic renal complications.

This article has been cited by other articles:

				I. Londono and M. Bendayan Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1201 - F1209. [Abstract] [Full Text] [PDF]

				Y. Hattori, M. Suzuki, S. Hattori, and K. Kasai Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts) Hypertension, January 1, 2002; 39(1): 22 - 28. [Abstract] [Full Text] [PDF]

				Z.-M. Bian, V. M. Elner, A. Yoshida, S. L. Kunkel, and S. G. Elner Signaling Pathways for Glycated Human Serum Albumin-Induced IL-8 and MCP-1 Secretion in Human RPE Cells Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1660 - 1668. [Abstract] [Full Text]

				I. Londono and M. Bendayan Temporary effects of circulating Amadori products on glomerular filtration properties in the normal mouse Am J Physiol Renal Physiol, January 1, 2001; 280(1): F103 - F111. [Abstract] [Full Text] [PDF]

				M. P. Cohen, F. N. Ziyadeh, G. T. Lautenslager, J. A. Cohen, and C. W. Shearman Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells Am J Physiol Renal Physiol, May 1, 1999; 276(5): F684 - F690. [Abstract] [Full Text] [PDF]

				K. Aida, M. Tawata, Y. Ikegishi, and T. Onaya Induction of Rat Aldose Reductase Gene Transcription Is Mediated through the cis-Element, Osmotic Response Element (ORE): Increased Synthesis and/or Activation by Phosphorylation of ORE-Binding Protein Is a Key Step Endocrinology, February 1, 1999; 140(2): 609 - 617. [Abstract] [Full Text]

				A. A. Booth, R. G. Khalifah, P. Todd, and B. G. Hudson In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs). NOVEL INHIBITION OF POST-AMADORI GLYCATION PATHWAYS J. Biol. Chem., February 28, 1997; 272(9): 5430 - 5437. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673